Skip Nav Destination
Issues
Cancer Research
Table of Contents
Advances in Brief
3-Deoxy-3-[18F]Fluorothymidine-Positron Emission Tomography for Noninvasive Assessment of Proliferation in Pulmonary Nodules
Andreas K. Buck; Holger Schirrmeister; Martin Hetzel; Mareike von der Heide; Gisela Halter; Gerhard Glatting; Torsten Mattfeldt; Florian Liewald; Sven N. Reske; Bernd Neumaier
Constitutive Activation of Signal Transducers and Activators of Transcription 3 Correlates with Cyclin D1 Overexpression and May Provide a Novel Prognostic Marker in Head and Neck Squamous Cell Carcinoma1
Muneyuki Masuda; Masumi Suzui; Ryuji Yasumatu; Torahiko Nakashima; Yuichiro Kuratomi; Kaoru Azuma; Kichinobu Tomita; Sohtaro Komiyama; I. Bernard Weinstein
Influence of Cytokine Gene Polymorphisms on the Development of Prostate Cancer1
Sarah L. McCarron; Stephen Edwards; Philip R. Evans; Roz Gibbs; David P. Dearnaley; Anna Dowe; Christine Southgate; The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators; Douglas F. Easton; Rosalind A. Eeles; W. Martin Howell
Biochemistry and Biophysics
Carcinogenesis
Deficiency of Either Cyclooxygenase (COX)-1 or COX-2 Alters Epidermal Differentiation and Reduces Mouse Skin Tumorigenesis
Howard F. Tiano; Charles D. Loftin; Jackie Akunda; Christopher A. Lee; Judson Spalding; Alisha Sessoms; David B. Dunson; Eleanor G. Rogan; Scott G. Morham; Robert C. Smart; Robert Langenbach
A Critical Role for ras-mediated, Epidermal Growth Factor Receptor-dependent Angiogenesis in Mouse Skin Carcinogenesis1
M. Llanos Casanova; Fernando Larcher; Benito Casanova; Rodolfo Murillas; M. Jesús Fernández-Aceñero; Concepción Villanueva; Jesús Martínez-Palacio; Axel Ullrich; Claudio J. Conti; Jose Luis Jorcano
Clinical Investigations
A Phase I Pharmacokinetic and Translational Study of the Novel Vascular Targeting Agent Combretastatin A-4 Phosphate on a Single-Dose Intravenous Schedule in Patients with Advanced Cancer1
Afshin Dowlati; Kelly Robertson; Matthew Cooney; William P. Petros; Michael Stratford; John Jesberger; Niusha Rafie; Beth Overmoyer; Vinit Makkar; Bruce Stambler; Anne Taylor; John Waas; Jonathan S. Lewin; Keith R. McCrae; Scot C. Remick
Endocrinology
Association of Interferon Regulatory Factor-1, Nucleophosmin, Nuclear Factor-κB, and Cyclic AMP Response Element Binding with Acquired Resistance to Faslodex (ICI 182,780)1
Zhiping Gu; Richard Y. Lee; Todd C. Skaar; Kerrie B. Bouker; James N. Welch; Jianping Lu; Aiyi Liu; Yuelin Zhu; Natalie Davis; Fabio Leonessa; Nils Brünner; Yue Wang; Robert Clarke
Experimental Therapeutics
Immunology
Molecular Biology and Genetics
Parallel Analysis of Sporadic Primary Ovarian Carcinomas by Spectral Karyotyping, Comparative Genomic Hybridization, and Expression Microarrays1, 2
Jane Bayani; James D. Brenton; Pascale F. Macgregor; Ben Beheshti; Monique Albert; Dhani Nallainathan; Jana Karaskova; Barry Rosen; Joan Murphy; Stephanie Laframboise; Brent Zanke; Jeremy A. Squire
Identification of Unstable Sequences within the Common Fragile Site at 3p14.2: Implications for the Mechanism of Deletions within Fragile Histidine Triad Gene/Common Fragile Site at 3p14.2 in Tumors1
Shantel Corbin; Mary E. Neilly; Rafael Espinosa, III; Elizabeth M. Davis; Timothy W. McKeithan; Michelle M. Le Beau
Artificial Neural Networks and Gene Filtering Distinguish Between Global Gene Expression Profiles of Barrett’s Esophagus and Esophageal Cancer1
Yan Xu; Florin M. Selaru; Jing Yin; Tong Tong Zou; Valentina Shustova; Yuriko Mori; Fumiaki Sato; Thomas C. Liu; Andreea Olaru; Suna Wang; Martha C. Kimos; Kellie Perry; Kena Desai; Bruce D. Greenwald; Mark J. Krasna; David Shibata; John M. Abraham; Stephen J. Meltzer
The RASSF1A Tumor Suppressor Gene Is Inactivated in Prostate Tumors and Suppresses Growth of Prostate Carcinoma Cells1
Igor Kuzmin; John W. Gillespie; Alexei Protopopov; Laura Geil; Koen Dreijerink; Youfeng Yang; Cathy D. Vocke; Fuh-Mei Duh; Eugene Zabarovsky; John D. Minna; Johng S. Rhim; Michael R. Emmert-Buck; W. Marston Linehan; Michael I. Lerman
Deregulated DNA Polymerase β Induces Chromosome Instability and Tumorigenesis1
Valérie Bergoglio; Marie-Jeanne Pillaire; Magali Lacroix-Triki; Brigitte Raynaud-Messina; Yvan Canitrot; Anne Bieth; Michèle Garès; Michel Wright; Georges Delsol; Lawrence A. Loeb; Christophe Cazaux; Jean-Sébastien Hoffmann
Tumor Biology
Frequencies of Tetramer+ T Cells Specific for the Wild-Type Sequence p53264–272 Peptide in the Circulation of Patients with Head and Neck Cancer1
Thomas K. Hoffmann; Albert D. Donnenberg; Sydney D. Finkelstein; Vera S. Donnenberg; Ulrike Friebe-Hoffmann; Eugene N. Myers; Ettore Appella; Albert B. DeLeo; Theresa L. Whiteside
Insulin Increases the Sensitivity of Tumors to Irradiation: Involvement of an Increase in Tumor Oxygenation Mediated by a Nitric Oxide-dependent Decrease of the Tumor Cells Oxygen Consumption1
Bénédicte F. Jordan; Vincent Grégoire; Roger J. Demeure; Pierre Sonveaux; Olivier Feron; Julia O’Hara; Valérie P. Vanhulle; Nathalie Delzenne; Bernard Gallez
Virology
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds